Viewing Study NCT01065935


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2025-12-31 @ 9:46 AM
Study NCT ID: NCT01065935
Status: COMPLETED
Last Update Posted: 2018-02-05
First Post: 2010-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Sponsor: Alnylam Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module